RVX is still very much under the radar.
As new investors discover it, they do some DD and discover a tightly held Phase 3 completed company with a novel drug with potential application in numerous medical indications.
That is why the price continues to rise.
Also, I would not be shocked to see some research coverage from a respectable source in the near future.
For now, accumulation continues .